Deliverable: PowerPoint Presentation

Primary Objective: Explore the market for ventricular assist devices (VADs)

Objectives:

·         Determine level of impact characteristics of VAD technology have on limiting its utilization

·         Evaluate Thoratec’s HeartMate II compared with current VAD technology

·         Identify the market for heart transplant surgery and the segment of this market applicable to VAD therapy

·         Rank VAD technology currently in development

Products Highlighted:

• CircuLite VAD, (CircuLite)
• Exeleras, (Orquis Medical)
• VentrAssist, (Ventracor)
• DuraHeart, (Terumo)
• HVAD, (Heartware)
• Levacor, (WorldHeart)
• Incor, (Berlin Heart)
• DeBakey VAD, (Micromed)
• Jarvik 2000, (Jarvik Heart)
• HeartMate II, (Thoratec)

Topics:

·         Factors affecting the utilization of VAD technology

·         Comparison of HeartMate II and current VAD technology

·         Heart-failure patients who could benefit from Implantation of a VAD under select    scenarios

·         Familiarity with devices

Screening Criteria:

·         50 US-based board-certified or board-eligible cardiothoracic surgeons and cardiologists

·         Have implanted at least 2 ventricular assist devices (VADs) in the past year

·         Familiar with Thoratec’s HeartMate II Device